EUVIMEDOtkrijte EUVIMED
QuerschnittstudieOpen access

User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study

Sara Browne iD, Anya Umlauf iD, David J Moore iD, Constance A Benson iD, Florin Vaida iD

JMIR mHealth and uHealth · 2024

DOI: 10.2196/53596 ↗

At a glance

Querschnittstudie in JMIR mHealth and uHealth, 2024. Written by Sara Browne and 4 co-authors. Institution: Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, United States. Major MEDLINE topics: HIV Infections, Pre-Exposure Prophylaxis. Cited 1 times so far (Crossref); 64 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS.

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Background

A digital health technology’s success or failure depends on how it is received by users.

Objectives

We conducted a user experience (UX) evaluation among persons who used the Food and Drug Administration–approved Digital Health Feedback System incorporating ingestible sensors (ISs) to capture medication adherence, after they were prescribed oral pre-exposure prophylaxis (PrEP) to prevent HIV infection. We performed an association analysis with baseline participant characteristics, to see if “personas” associated with positive or negative UX emerged.

Methods

UX data were collected upon exit from a prospective intervention study of adults who were HIV negative, prescribed oral PrEP, and used the Digital Health Feedback System with IS-enabled tenofovir disoproxil fumarate plus emtricitabine (IS-Truvada). Baseline demographics; urine toxicology; and self-report questionnaires evaluating sleep (Pittsburgh Sleep Quality Index), self-efficacy, habitual self-control, HIV risk perception (Perceived Risk of HIV Scale 8-item), and depressive symptoms (Patient Health Questionnaire–8) were collected. Participants with ≥28 days in the study completed a Likert-scale UX questionnaire of 27 questions grouped into 4 domain categories: overall experience, ease of use, intention of future use, and perceived utility. Means and IQRs were computed for participant total and domain subscores, and linear regressions modeled baseline participant characteristics associated with UX responses. Demographic characteristics of responders versus nonresponders were compared using the Fisher exact and Wilcoxon rank-sum tests.

Results

Overall, 71 participants were enrolled (age: mean 37.6, range 18-69 years; n=64, 90% male; n=55, 77% White; n=24, 34% Hispanic; n=68, 96% housed; and n=53, 75% employed). No demographic differences were observed in the 63 participants who used the intervention for ≥28 days. Participants who completed the questionnaire were more likely to be housed (52/53, 98% vs 8/10, 80%; P =.06) and less likely to have a positive urine toxicology (18/51, 35% vs 7/10, 70%; P =.08), particularly methamphetamine (4/51, 8% vs 4/10, 40%; P =.02), than noncompleters. Based on IQR values, ≥75% of participants had a favorable UX based on the total score (median 3.78, IQR 3.17-4.20), overall experience (median 4.00, IQR 3.50-4.50), ease of use (median 3.72, IQR 3.33-4.22), and perceived utility (median 3.72, IQR 3.22-4.25), and ≥50% had favorable intention of future use (median 3.80, IQR 2.80-4.40). Following multipredictor modeling, self-efficacy was significantly associated with the total score (0.822, 95% CI 0.405-1.240; P

Subjects

MeSH terms (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisHumansMaleFemaleAdultMiddle AgedCross-Sectional StudiesProspective StudiesSurveys and QuestionnairesMedication AdherenceDrug Monitoring

Author keywords

HIVHIV preventionSTDSTIUXadherencecompliancedrugdrugsingestible sensormedicationmedication adherencemedicationsoralpharmaceutic

Authors and institutions

  • Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, United States.
  • Specialists in Global Health, Encinitas, CA, United States.
  • Department of Psychiatry, University of California San Diego, San Diego, CA, United States.
  • Department of Family Medicine and Public Health, University of California San Diego, San Diego, CA, United States.

ORCID profiles: Sara Browne, Anya Umlauf, David J Moore, Constance A Benson, Florin Vaida

Funding

  • NIMH NIH HHS

Cite

APA

Browne, S., Umlauf, A., Moore, D. J., Benson, C. A., & Vaida, F. (2024). User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study. JMIR mHealth and uHealth. https://doi.org/10.2196/53596

Vancouver

Browne S, Umlauf A, Moore DJ, Benson CA, Vaida F. User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study. JMIR mHealth and uHealth. 2024. doi:10.2196/53596

BibTeX
@article{Browne2024,
  author = {Browne, Sara and Umlauf, Anya and Moore, David J and Benson, Constance A and Vaida, Florin},
  title = {User Experience of Persons Using Ingestible Sensor–Enabled Pre-Exposure Prophylaxis to Prevent HIV Infection: Cross-Sectional Survey Study},
  journal = {JMIR mHealth and uHealth},
  year = {2024},
  doi = {10.2196/53596}
}
Start for free →